CHANTE FASON: Open Payments
NPI 1902966765 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,229 in 142 payments from 15 companies in 2025. Trend: 2023 $3,334 · 2024 $2,950 · 2025 $3,229
Food & beverage: $3,229
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $519 |
| Alkermes, Inc. | 15 | $504 |
| ABBVIE INC. | 18 | $497 |
| Otsuka America Pharmaceutical, Inc. | 25 | $447 |
| Neurocrine BioSciences, Inc. | 13 | $253 |
| Vanda Pharmaceuticals Inc. | 14 | $251 |
| Janssen Pharmaceuticals, Inc | 11 | $194 |
| Axsome Therapeutics, Inc. | 9 | $167 |
| Bausch Health US, LLC | 5 | $119 |
| ACADIA Pharmaceuticals Inc | 5 | $99 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, INGREZZA, LYBALVI, Auvelity, HETLIOZ.
Industry payments across TN — which companies pay providers there.
